Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport in the treatment of forehead and glabellar lines
IRCT201209179844N2Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A in glabellar furrowing, sponsored by Tabriz University of Medical Sciences. Started Apr 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on IRCT201209179844N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201209179844N2.